Doctor profile · Federal record
Dr. Margaret Kinsella, M.D.
Rheumatology Physician · Bellingham, WA
- NPI 1962523084
- MIPS 77.1 / 100 · 2023
- 19 yrs on file
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
470 Birchwood Ave, Suite C
Bellingham, WA 982251781
(360) 676-1610 - Mailing address
-
470 Birchwood Ave Ste C, Suite C
Bellingham, WA 982251781
Credentials & registration
- NPI registered
- April 2007 — 19 yrs on file
- Profile last updated
- June 1, 2012
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Washington #MD0004725
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1962523084. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
88,904
Distinct HCPCS
10
Medicare allowed
$1,109,229
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 40,780 | 11 | $6 | |
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 30,400 | 26 | $5 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 7,055 | 34 | $32 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 4,650 | 12 | $42 | |
Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 3,140 | 23 | $43 | |
J0897 |
Injection, denosumab, 1 mg | 1,080 | 14 | $23 | |
J7050 |
Infusion, normal saline solution, 250 cc | 415 | 68 | $1 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 330 | 46 | $29 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 240 | 157 | $129 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 223 | 48 | $134 |
In context: peer comparison
Among 3 peers in Bellingham Rheumatology Physician, average services per provider: 3,880. This provider delivers 23× the peer median.Open Payments
Industry payments received
All-time total
$254
Transactions
11
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 4 | $89.10 | |
| Kiniksa Pharmaceuticals International, Plc | 2 | $42.32 | |
| Organon LLC | 1 | $31.84 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $28.14 | |
| Genentech USA, INC. | 1 | $21.83 | |
| Novartis Pharmaceuticals Corporation | 1 | $21.28 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $19.89 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,615
Patients
325
Total drug cost
$775,573
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 477 | 128 | $5,446 |
| Methotrexate (Methotrexate Sodium) | Brand | 471 | 101 | $14,411 |
| Hydroxychloroquine Sulfate | Generic | 155 | 37 | $11,440 |
| Leucovorin Calcium | Generic | 84 | 20 | $1,199 |
| Allopurinol | Generic | 75 | 13 | $830 |
| Enbrel Sureclick (Etanercept) | Brand | 55 | 0 | $425,979 |
| Omeprazole | Generic | 53 | 14 | $426 |
| Sulfasalazine | Generic | 48 | 12 | $1,370 |
| Leflunomide | Generic | 46 | 0 | $3,101 |
| Mycophenolate Mofetil | Generic | 41 | 0 | $5,479 |
Frequently asked questions
What is Dr. Margaret Kinsella's medical specialty?
Dr. Margaret Kinsella practices Rheumatology Physician in Bellingham, WA.
Where does Dr. Margaret Kinsella practice?
Dr. Margaret Kinsella practices at 470 Birchwood Ave, Bellingham, WA 982251781. Office phone: 3606761610.
What is Dr. Margaret Kinsella's NPI?
Dr. Margaret Kinsella's National Provider Identifier (NPI) is 1962523084, issued by NPPES.
What procedures does Dr. Margaret Kinsella commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.